In recent decades, treatment advances have helped people with cancer live longer and better lives. Scientific investments have led to breakthroughs not previously imaginable, such as the development of immunotherapies and precision medicines. However
Read More...
Read the complete post at http://healthaffairs.org/blog/2017/04/03/overcoming-challenges-of-outcomes-based-contracting-for-pharmaceuticals-early-lessons-from-the-genentech-priority-health-pilot/
Posted
Apr 03 2017, 09:37 AM
by
Health Affairs BlogHealth Affairs Blog